In 2023, Germany led the global export market of insulin in dosage forms with a dominant share, followed by France and Italy. The collective European countries showcased a commanding presence, with China and the United States also contributing meaningfully but at a much lower scale. Notably, smaller players such as Latvia and Greece demonstrated significant year-on-year growth rates, even though their overall market share remained minor.
Future trends worth monitoring include potential market expansion in growing regions like Eastern Europe and Asia due to increased demand and rising healthcare investments. Additionally, technological advancements and changes in regulatory frameworks could reshape market dynamics.
Top countries in Export of Insulin in Dosage Forms Share by Country (US Dollars)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 44.79 | 2023 | +0.51% | +2.22% | View data |
| 2 | 2 France | 28.87 | 2023 | +2.23% | +1.03% | View data |
| 3 | 3 Italy | 11.87 | 2023 | +4.72% | +4.84% | View data |
| 4 | 4 China | 5.2 | 2023 | +5.55% | +4.51% | View data |
| 5 | 5 United States | 2.44 | 2023 | -1.53% | +0.043% | View data |
| 6 | 6 India | 1.84 | 2023 | +3.09% | +3.39% | View data |
| 7 | 7 Hungary | 0.99 | 2023 | +2.22% | +1.6% | View data |
| 8 | 8 Belgium | 0.94 | 2023 | +4.46% | +4.4% | View data |
| 9 | 9 United Kingdom | 0.93 | 2023 | +2.84% | +3.11% | View data |
| 10 | 10 Czech Republic | 0.82 | 2023 | +4.06% | +2.87% | View data |
